Urteste Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Urteste's earnings have been declining at an average annual rate of -29.1%, while the Biotechs industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 100% per year.
Belangrijke informatie
-29.1%
Groei van de winst
30.8%
Groei van de winst per aandeel
| Biotechs Groei van de industrie | 56.3% |
| Inkomstengroei | 100.0% |
| Rendement op eigen vermogen | -16.5% |
| Nettomarge | n/a |
| Volgende winstupdate | 28 Nov 2024 |
Recente prestatie-updates uit het verleden
Opbrengsten en kosten
Hoe Urteste geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 0 | -4 | 6 | 0 |
| 31 Mar 24 | 1 | -5 | 7 | 0 |
| 31 Dec 23 | 0 | -6 | 6 | 0 |
| 30 Sep 23 | 0 | -6 | 5 | 0 |
| 30 Jun 23 | 0 | -5 | 4 | 0 |
| 31 Mar 23 | 0 | -4 | 4 | 0 |
| 31 Dec 22 | 0 | -4 | 3 | 0 |
| 31 Dec 21 | 0 | -2 | 2 | 0 |
Kwaliteitswinsten: URT is currently unprofitable.
Groeiende winstmarge: URT is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: URT is unprofitable, and losses have increased over the past 5 years at a rate of 29.1% per year.
Versnelling van de groei: Unable to compare URT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: URT is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-20.8%).
Rendement op eigen vermogen
Hoge ROE: URT has a negative Return on Equity (-16.54%), as it is currently unprofitable.